172 related articles for article (PubMed ID: 36445654)
1. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
[TBL] [Abstract][Full Text] [Related]
2. Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study.
Hatta W; Koike T; Takahashi S; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Matsumoto T; Nakamura T; Nakaya N; Iijima K; Fukuda S; Masamune A;
J Gastroenterol; 2021 Jul; 56(7):620-632. PubMed ID: 33881632
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.
Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y
Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897
[TBL] [Abstract][Full Text] [Related]
4. Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection.
Shimada T; Hatta W; Takahashi S; Koike T; Ohira T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Nakamura J; Matsumoto T; Iijima K; Fukuda S; Masamune A; Ito K;
Dig Endosc; 2022 Nov; 34(7):1382-1391. PubMed ID: 35702926
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
[TBL] [Abstract][Full Text] [Related]
6. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
Yang X; Zhao L; Shi A; Chen C; Cao J; Zhang Y; Zhu H; Wang J; Zhou W; Li X; Hu S; Men Y; Wang J; Xue L; Liu Y; Dou L; Zhang Y; Sun S; Yuan M; Bao Y; Ma Z; Liu Y; Zhang W; Bi N; Wang G; Hui Z
Am J Gastroenterol; 2023 Aug; 118(8):1344-1352. PubMed ID: 36972240
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
[TBL] [Abstract][Full Text] [Related]
10. Prognostic risk factors associated with esophageal squamous cell carcinoma patients undergoing endoscopic submucosal dissection: a multi-center cohort study.
Iwai N; Dohi O; Yamada S; Harusato A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Kimura H; Yagi N; Naito Y; Itoh Y
Surg Endosc; 2022 Apr; 36(4):2279-2289. PubMed ID: 33860352
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gingivalis predicts local recurrence after endoscopic submucosal dissection of early esophageal squamous cell carcinoma or precancerous lesion.
Gao SG; Qi ZP; Qi YJ; Hou YY; Liu YW; Li MX; Li B; Sun D; Shi Q; Cai SL; Zhou PH; Zhong YS
BMC Cancer; 2023 Jan; 23(1):43. PubMed ID: 36635649
[TBL] [Abstract][Full Text] [Related]
13. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma.
Takahashi K; Hashimoto S; Mizuno KI; Kobayashi T; Tominaga K; Sato H; Kohisa J; Ikarashi S; Hayashi K; Takeuchi M; Yokoyama J; Kawai H; Sato Y; Kobayashi M; Terai S
Endoscopy; 2018 Jul; 50(7):662-670. PubMed ID: 29272907
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence risk of esophageal squamous cell carcinoma due to intralesional damage during endoscopic submucosal dissection.
Minamide T; Kawata N; Maeda Y; Yoshida M; Yamamoto Y; Ashizawa H; Takada K; Kishida Y; Ito S; Imai K; Hotta K; Sato J; Ishiwatari H; Matsubayashi H; Sugino T; Ono H
J Gastroenterol Hepatol; 2023 Oct; 38(10):1802-1807. PubMed ID: 37519057
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma with Relative Indications.
Liu Y; Qian D; Tang B; Fan C; Yu J; Lin H; Bai J; Zhao X
Dig Surg; 2021; 38(1):14-23. PubMed ID: 33271540
[TBL] [Abstract][Full Text] [Related]
16. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy.
Wang CY; Chen BH; Lee CH; Le PH; Tsou YK; Lin CH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053586
[TBL] [Abstract][Full Text] [Related]
17. Repeat endoscopic submucosal dissection as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial endoscopic submucosal dissection.
Xu JQ; Zhang ZC; Chen WF; Xu MD; Chen SY; Zhong YS; Zhang YQ; Hu JW; Cai MY; Yao LQ; Zhou PH; Li QL
Gastrointest Endosc; 2022 Jul; 96(1):18-27.e1. PubMed ID: 35240119
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma.
Minamide T; Kawata N; Maeda Y; Yoshida M; Yamamoto Y; Takada K; Kishida Y; Ito S; Imai K; Hotta K; Sato J; Ishiwatari H; Matsubayashi H; Ono H
Gastrointest Endosc; 2023 Feb; 97(2):232-240.e4. PubMed ID: 36228694
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma: a propensity score matching analysis.
Huang R; Cai H; Zhao X; Lu X; Liu M; Lv W; Liu Z; Wu K; Han Y
Gastrointest Endosc; 2017 Nov; 86(5):831-838. PubMed ID: 28286094
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis after endoscopic resection of T1a-MM/T1b-SM1 esophageal squamous cell carcinoma.
Ohki D; Tsuji Y; Shinozaki T; Sakaguchi Y; Mizutani H; Nagao S; Miura Y; Fukagawa K; Tamura N; Yakabi S; Yamamichi N; Fujishiro M
Medicine (Baltimore); 2022 Dec; 101(49):e32115. PubMed ID: 36626416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
